<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SGLT2 HYPE</title>
	<atom:link href="https://www.sglt2-hype.eu/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.sglt2-hype.eu</link>
	<description>A project for improving hypertension treatment</description>
	<lastBuildDate>Tue, 25 Nov 2025 07:25:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
	<item>
		<title>SGLT2 newsletter #1</title>
		<link>https://www.sglt2-hype.eu/newsletter/sglt2-newsletter-1/</link>
		
		<dc:creator><![CDATA[Florian]]></dc:creator>
		<pubDate>Mon, 24 Nov 2025 16:27:58 +0000</pubDate>
				<category><![CDATA[Newsletter]]></category>
		<guid isPermaLink="false">https://www.sglt2-hype.eu/?p=1653</guid>

					<description><![CDATA[<p>Discover the focus of our first SGLT2-Hype newsletter: an overview of groundbreaking new studies on SGLT2 inhibitors in heart failure and kidney protection, expert insights into clinical relevance, and a preview of upcoming research highlights.</p>
<p>The post <a href="https://www.sglt2-hype.eu/newsletter/sglt2-newsletter-1/">SGLT2 newsletter #1</a> first appeared on <a href="https://www.sglt2-hype.eu">SGLT2 HYPE</a>.</p>]]></description>
		
		
		
			</item>
		<item>
		<title>New EU-funded Project Aims to Transform Hypertension Treatment</title>
		<link>https://www.sglt2-hype.eu/wp-content/uploads/SGLT2_HYPE_PressRelease_Project_ProjectStart_final.pdf#new_tab</link>
		
		<dc:creator><![CDATA[Florian]]></dc:creator>
		<pubDate>Sat, 05 Apr 2025 13:39:05 +0000</pubDate>
				<category><![CDATA[Press release]]></category>
		<guid isPermaLink="false">https://www.sglt2-hype.eu/?p=725</guid>

					<description><![CDATA[<p>SGLT2 HYPE is a guideline-relevant clinical trial aiming to establish SGLT2 inhibitors as a new standard in high blood pressure therapy, ultimately addressing one of the leading causes of premature mortality in Europe</p>
<p>The post <a href="https://www.sglt2-hype.eu/wp-content/uploads/SGLT2_HYPE_PressRelease_Project_ProjectStart_final.pdf#new_tab">New EU-funded Project Aims to Transform Hypertension Treatment</a> first appeared on <a href="https://www.sglt2-hype.eu">SGLT2 HYPE</a>.</p>]]></description>
		
		
		
			</item>
		<item>
		<title>Kick-Off meeting</title>
		<link>https://www.sglt2-hype.eu/events/kick-off-meeting/</link>
		
		<dc:creator><![CDATA[Florian]]></dc:creator>
		<pubDate>Tue, 25 Mar 2025 05:21:38 +0000</pubDate>
				<category><![CDATA[Events]]></category>
		<guid isPermaLink="false">https://www.sglt2-hype.eu/?p=1154</guid>

					<description><![CDATA[<p>SGLT2 HYPE Kicks Off with Momentum: A New Chapter in Hypertension Research Begins</p>
<p>The post <a href="https://www.sglt2-hype.eu/events/kick-off-meeting/">Kick-Off meeting</a> first appeared on <a href="https://www.sglt2-hype.eu">SGLT2 HYPE</a>.</p>]]></description>
		
		
		
			</item>
	</channel>
</rss>
